Global Cord Blood Corporation (CO) Dividends
Dividend Yield and Dividend History Highlights
- Regarding free cash flow variation: CO reports less variability in its cash flow than 95.5% of dividend stocks in our set.
- The stock's free cash flow/dividend ratio, potentially useful for understanding its ability to make dividend payments, comes in at -41.93 -- higher than merely 1.78% of other dividend issuers in the US.
- CO has an EBITDA to net debt ratio of 404,749,000; for context, that's better than 95.65% stocks in our set (note that its net debt is negative, meaning it has more cash than debt).
- As for stocks whose price is uncorrelated with CO's price and thus may be suitable peers for a diversified dividend portfolio, check out the following: HL, TNP, HIMX, AMGN and HD.
CO Dividend Chart
CO Dividend History
|Ex-Dividend Date||Type||Payout Amount||Change|
|Loading, please wait...|
CO Dividends vs. Peers
CO's dividend yield currently ranks #33 of 86 vs. its peers in the Medical - Diagnostics/Research category.